JP Morgan Chase
TAK icon

JP Morgan Chase’s Takeda Pharmaceutical TAK Stock Holding History

JP Morgan Chase’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-427,550
Closed -$7.51M – 5951
2019
Q2 		$7.51M Hold
427,550
– – ﹤0.01% 2325
2019
Q1 		$8.71M Buy
+427,550
New +$8.6M ﹤0.01% 2170

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

JP Morgan Chase's TAK Position: Q2 2026 in Review

JP Morgan Chase increased its Takeda Pharmaceutical (TAK) stake by 64% in Q2 2026, buying an estimated $4.81M and bringing the position to 744,916 shares worth $11.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2654.

JP Morgan Chase first reported a position in TAK in Q4 2018 and has held it in 31 quarters since. 379 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • JP Morgan Chase held 744,916 shares of Takeda Pharmaceutical worth $11.9M as of Q2 2026.
  • JP Morgan Chase bought 290,935 Takeda Pharmaceutical shares in Q2 2026, an estimated $4.81M.
  • Takeda Pharmaceutical made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #2654 holding.
  • JP Morgan Chase first reported a position in Takeda Pharmaceutical in Q4 2018 and has held it in 31 quarters since.
  • 379 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.